Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease?
Prognostic parameters are crucial in the choice of treatment in Graves' disease (GD), thus,these parameters may not be easily achievable in all situations. However hematological parameters is important in inflammation and easy to obtain. In this study we aimed to elucidate whether these p...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Turaz Bilim
2022-12-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=89510 |
| _version_ | 1797327908380868608 |
|---|---|
| author | Ozden Ozdemir Baser Derya Koseoglu Merve Catak |
| author_facet | Ozden Ozdemir Baser Derya Koseoglu Merve Catak |
| author_sort | Ozden Ozdemir Baser |
| collection | DOAJ |
| description | Prognostic parameters are crucial in the choice of treatment in Graves' disease (GD), thus,these parameters may not be easily achievable in all situations. However hematological parameters is important in inflammation and easy to obtain. In this study we aimed to elucidate whether these parameters could determine the prognosis in patients with Graves Disease. This retrospective analysis consisted of 114 individuals with a diagnosed with GD. The enrolled patients were treated with anti-thyroid drugs for an average of 14 months and the mean follow-up period after treatment discontinuation was 17.4 months. After the follow-up period subjects have been segmented to 2 groups as: Group 1 relapsed (n:61) and Group 2 non-relapsed (n:53). The neutrophil to lymphocyte ratio (NLR) of the relapsing individual was statistically significantly higher compared to other group, while the eosinophil to monocytes ratio (EMR) was lower. In the multiregression analysis, both parameters were found to be independent risk factors in predicting relapse [(OR=3.1, p:0.026 for NLR) (OR=1.5, p [Med-Science 2022; 11(4.000): 1436-40] |
| first_indexed | 2024-03-08T06:43:35Z |
| format | Article |
| id | doaj.art-b048c8b663bc46e69edd4185697f0b50 |
| institution | Directory Open Access Journal |
| issn | 2147-0634 |
| language | English |
| last_indexed | 2024-03-08T06:43:35Z |
| publishDate | 2022-12-01 |
| publisher | Society of Turaz Bilim |
| record_format | Article |
| series | Medicine Science |
| spelling | doaj.art-b048c8b663bc46e69edd4185697f0b502024-02-03T08:19:15ZengSociety of Turaz BilimMedicine Science2147-06342022-12-0111414364010.5455/medscience.2022.07.16789510Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease?Ozden Ozdemir Baser0Derya Koseoglu1Merve Catak2Yozgat City Hospital, Department of Endocrinology and Metabolism, Yozgat, Turkiye Hitit University Erol Olcok Education and Research Hospital, Department of Endocrinology and Metabolism, Corum, Turkiye Gaziosmanpasa University, Department of Endocrinology and Metabolism, Tokat, TurkiyePrognostic parameters are crucial in the choice of treatment in Graves' disease (GD), thus,these parameters may not be easily achievable in all situations. However hematological parameters is important in inflammation and easy to obtain. In this study we aimed to elucidate whether these parameters could determine the prognosis in patients with Graves Disease. This retrospective analysis consisted of 114 individuals with a diagnosed with GD. The enrolled patients were treated with anti-thyroid drugs for an average of 14 months and the mean follow-up period after treatment discontinuation was 17.4 months. After the follow-up period subjects have been segmented to 2 groups as: Group 1 relapsed (n:61) and Group 2 non-relapsed (n:53). The neutrophil to lymphocyte ratio (NLR) of the relapsing individual was statistically significantly higher compared to other group, while the eosinophil to monocytes ratio (EMR) was lower. In the multiregression analysis, both parameters were found to be independent risk factors in predicting relapse [(OR=3.1, p:0.026 for NLR) (OR=1.5, p [Med-Science 2022; 11(4.000): 1436-40]http://www.ejmanager.com/fulltextpdf.php?mno=89510graves' diseaseneutrophil to lymphocyte ratioeosinophil to monocytes ratioprognostic parametershematological parameters |
| spellingShingle | Ozden Ozdemir Baser Derya Koseoglu Merve Catak Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? Medicine Science graves' disease neutrophil to lymphocyte ratio eosinophil to monocytes ratio prognostic parameters hematological parameters |
| title | Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? |
| title_full | Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? |
| title_fullStr | Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? |
| title_full_unstemmed | Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? |
| title_short | Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? |
| title_sort | can eosinophil to monocyte ratio be a new marker for recurrence in graves apos disease |
| topic | graves' disease neutrophil to lymphocyte ratio eosinophil to monocytes ratio prognostic parameters hematological parameters |
| url | http://www.ejmanager.com/fulltextpdf.php?mno=89510 |
| work_keys_str_mv | AT ozdenozdemirbaser caneosinophiltomonocyteratiobeanewmarkerforrecurrenceingravesaposdisease AT deryakoseoglu caneosinophiltomonocyteratiobeanewmarkerforrecurrenceingravesaposdisease AT mervecatak caneosinophiltomonocyteratiobeanewmarkerforrecurrenceingravesaposdisease |